Lantheus Holdings, Inc. Related Party Transaction, Expenses from Transactions with Related Party
Lantheus Holdings, Inc. (LNTH) reported Related Party Transaction, Expenses from Transactions with Related Party of $623.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2018-02-26
- Lantheus Holdings, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Lantheus Holdings, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- Lantheus Holdings, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2017-06-30 was $266.00K, a 36.36% decline year-over-year.
- Lantheus Holdings, Inc. related party transaction, expenses from transactions with related party for the quarter ending 2017-03-31 was $357.00K, a 32.71% increase year-over-year.
- Lantheus Holdings, Inc. related party transaction, expenses from transactions with related party for fiscal 2017 was $623.00K, a 45.64% decline from fiscal 2016.
- Lantheus Holdings, Inc. related party transaction, expenses from transactions with related party for fiscal 2016 was $1.15M, a 84.30% decline from fiscal 2015.
- Lantheus Holdings, Inc. related party transaction, expenses from transactions with related party for fiscal 2015 was $7.30M, a 386.67% increase from fiscal 2014.
- Lantheus Holdings, Inc. related party transaction, expenses from transactions with related party for fiscal 2014 was $1.50M.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 6 month | Related Party Transaction, Expenses from Transactions with Related Party 9 month | Related Party Transaction, Expenses from Transactions with Related Party 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 derived: sum of 2 quarters · filed 2018-02-26 | $266.00K derived: sum of 3 quarters · filed 2018-02-26 | $623.00K 10-K · filed 2018-02-26 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 | $266.00K derived: sum of 2 quarters · filed 2017-11-02 | $623.00K 10-Q · filed 2017-11-02 | $877.00K derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-06-30 | $266.00K 10-Q · filed 2017-08-01 | $623.00K 10-Q · filed 2017-08-01 | $877.00K derived: sum of 3 quarters · filed 2018-02-26 | $1.23M derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-03-31 | $357.00K 10-Q · filed 2017-05-02 | $611.00K derived: sum of 2 quarters · filed 2018-02-26 | $964.00K derived: sum of 3 quarters · filed 2018-02-26 | $1.38M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-12-31 | $254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $607.00K derived: sum of 2 quarters · filed 2018-02-26 | $1.02M derived: sum of 3 quarters · filed 2018-02-26 | $1.15M 10-K · filed 2018-02-26 |
| 2016-09-30 | $353.00K 10-Q · filed 2017-11-02 | $771.00K derived: sum of 2 quarters · filed 2017-11-02 | $892.00K 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $418.00K 10-Q · filed 2017-08-01 | $645.00K 10-Q · filed 2017-08-01 | ||
| 2016-03-31 | $269.00K 10-Q · filed 2017-05-02 | |||
| 2015-12-31 | $7.30M 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $1.50M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |